| Primary |
| Dry Eye |
42.7% |
| Product Used For Unknown Indication |
27.8% |
| Hypertension |
6.4% |
| Supplementation Therapy |
3.3% |
| Hypothyroidism |
3.2% |
| Blood Cholesterol Increased |
2.7% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Glaucoma |
1.7% |
| Hypersensitivity |
1.2% |
| Insomnia |
1.2% |
| Asthma |
1.1% |
| Anxiety |
1.0% |
| Depression |
0.9% |
| Eye Lubrication Therapy |
0.9% |
| Cardiac Disorder |
0.7% |
| Sjogren's Syndrome |
0.7% |
| Arthritis |
0.6% |
| Rosacea |
0.6% |
| Hormone Replacement Therapy |
0.5% |
| Postoperative Care |
0.5% |
|
| Vision Blurred |
21.5% |
| Eye Irritation |
17.1% |
| Ocular Hyperaemia |
14.4% |
| Lacrimation Increased |
6.0% |
| Drug Ineffective |
5.2% |
| Eye Pain |
4.5% |
| Scleral Hyperaemia |
3.7% |
| Eye Pruritus |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
| Foreign Body Sensation In Eyes |
2.6% |
| Headache |
2.6% |
| Rash |
2.6% |
| Instillation Site Pain |
2.4% |
| Visual Acuity Reduced |
2.1% |
| Incorrect Dose Administered |
1.6% |
| Superficial Injury Of Eye |
1.6% |
| Burning Sensation |
1.3% |
| Inappropriate Schedule Of Drug Administration |
1.3% |
| Pruritus |
1.3% |
| Urticaria |
1.3% |
|
| Secondary |
| Dry Eye |
44.0% |
| Product Used For Unknown Indication |
20.7% |
| Hypertension |
6.5% |
| Hypothyroidism |
3.8% |
| Eye Irritation |
3.3% |
| Blood Cholesterol Increased |
2.7% |
| Insomnia |
2.7% |
| Supplementation Therapy |
2.2% |
| Anxiety |
1.6% |
| Asthma |
1.6% |
| Excessive Eye Blinking |
1.6% |
| Hypersensitivity |
1.6% |
| Arthritis |
1.1% |
| Cataract |
1.1% |
| Depression |
1.1% |
| Eye Lubrication Therapy |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Rosacea |
1.1% |
| Abnormal Sensation In Eye |
0.5% |
| Anticoagulant Therapy |
0.5% |
|
| Vision Blurred |
27.5% |
| Ocular Hyperaemia |
17.6% |
| Drug Ineffective |
5.9% |
| Eye Irritation |
5.9% |
| Incorrect Dose Administered |
3.9% |
| Lacrimation Increased |
3.9% |
| Scleral Hyperaemia |
3.9% |
| Urinary Tract Infection |
3.9% |
| Visual Impairment |
3.9% |
| Vitreous Detachment |
3.9% |
| Blood Pressure Inadequately Controlled |
2.0% |
| Dizziness |
2.0% |
| Erythema |
2.0% |
| Eye Discharge |
2.0% |
| Eye Pain |
2.0% |
| Eyelids Pruritus |
2.0% |
| Headache |
2.0% |
| Inappropriate Schedule Of Drug Administration |
2.0% |
| Incorrect Product Storage |
2.0% |
| Instillation Site Dryness |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.8% |
| Dry Eye |
19.3% |
| Growth Of Eyelashes |
13.8% |
| Hypersensitivity |
3.7% |
| Hypertension |
2.8% |
| Ocular Surface Disease |
2.8% |
| Conjunctivitis Allergic |
1.8% |
| Dyspepsia |
1.8% |
| Eczema |
1.8% |
| Eye Lubrication Therapy |
1.8% |
| Glaucoma |
1.8% |
| Hormone Replacement Therapy |
1.8% |
| Hypothyroidism |
1.8% |
| Hypotrichosis |
1.8% |
| Nasal Irrigation |
1.8% |
| Sjogren's Syndrome |
1.8% |
| Blood Cholesterol Increased |
0.9% |
| Cardiac Disorder |
0.9% |
| Cataract Operation |
0.9% |
| Dry Mouth |
0.9% |
|
| Wrong Technique In Drug Usage Process |
30.8% |
| Eye Pruritus |
7.7% |
| Ocular Hyperaemia |
7.7% |
| Photophobia |
7.7% |
| Therapeutic Response Decreased |
7.7% |
| Hypersensitivity |
3.8% |
| Impaired Driving Ability |
3.8% |
| Inappropriate Schedule Of Drug Administration |
3.8% |
| Intraocular Pressure Increased |
3.8% |
| Pruritus |
3.8% |
| Punctate Keratitis |
3.8% |
| Rash |
3.8% |
| Skin Exfoliation |
3.8% |
| Skin Irritation |
3.8% |
| Trichorrhexis |
3.8% |
|
